Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy programs were updated Jan. 1, 2025:
Effective Feb. 1, 2025:
- Androgens and Anabolic Steroids
- Antifungals
- Bevacizumab
- CGM
- Coverage Exception
- Denosumab Oncology
- Denosumab Osteoporosis
- Epinephrine
- Furoscix
- IL-31 Inhibitors
- Lenmeldy
- Procysbi
- Progesterones
- Resmetirom
- Scenesse
- Syfovre
- Topical Doxepin
- Vasomotor Symptoms
- Weight Loss Agents
- Winlevi
- Zoryve
- Ocular Angiogenesis
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.